| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |